Propriedades psicométricas do WHOQOL-HIV Bref para avaliação da qualidade de vida / Psychometric properties of the WHOQOL-HIV Bref for quality of life assessment / Propiedades psicométricas del WHOQOL-VIH Bref para evaluación de calidad de vida

Objetivo: Avaliar as propriedades psicométricas do questionário WHOQOL-HIV Bref em pessoas com HIV/AIDS. Método: O instrumento foi aplicado a 226 pessoas com HIV/AIDS do Norte de Minas Gerais. As propriedades psicométricas foram avaliadas pela validade de construto, análise da confiabilidade e validade de critério. Resultados: O modelo com seis domínios apresentou ajustamento aceitável (χ2/gl= 1,77, p <0,001, GFI = 0,85, CFI= 0,89, RMSEA = 0,058 ). O WHOQOL-HIV Bref apresentou correlações estatisticamente significativas entre os seis domínios, consistência interna e reprodutibilidade satisfatórias. Os escores dos domínios demonstraram correlação significativa com o escore da qualidade de vida geral e dos itens que avaliam a autopercepção da qualidade de vida e da saúde, correlação significativa com o resultado global da depressão e diferenças estatisticamente significativas entre subgrupos de pacientes segundo variáveis socioeconômicas e clínicas. Conclusões: O WHOQOL-HIV Bref apresentou-se válido, confiável para medir a qualidade de vida de pessoas com HIV/AIDS. (AU)

Objective: To evaluate the psychometric properties of the WHOQOL-HIV Bref questionnaire in people with HIV / AIDS. Method: The questionnaire was applied to 226 people living with HIV/AIDS in the Northern part of the state of Minas Gerais. The psychometric properties were evaluated by construct validity, reliability analysis, and criteria validity. Results: The model with six domains had an acceptable adjustment (χ2 / gl = 1.77, p <0.001, GFI = 0.85, CFI = 0.89, RMSEA = 0.058). The WHOQOL-HIV Bref showed statistically significant correlations among the six domains, satisfactory internal consistency and reproducibility. The instrument scores showed a significant correlation with the general quality of life score and the items that assess the self-perception of quality of life and health, a significant correlation with the overall result of depression, and statistically significant differences between subgroups of patients. Conclusions: The WHOQOL-HIV Bref was valid, reliable to measure the quality of life of people with HIV/AIDS. (AU)

Objetivo: Evaluar las propiedades psicométricas del cuestionario WHOQOL- HIV Bref en personas con HIV/SIDA. Método: El instrumento fue aplicado a 226 personas con HIV/SIDA del Norte de Minas Gerais. Las propiedades psicométricas fueron evaluadas por validez de constructo, análisis de confiabilidad, y validez de criterio. Resultados: El modelo con seis dominios presentó un ajuste aceptable (χ2 / gl = 1,77, p <0,001, GFI = 0,85, CFI = 0,89, RMSEA = 0,058). El WHOQOL-HIV Bref presentó correlaciones estadísticamente significativas entre los seis dominios, consistencia interna, y reproductibilidad satisfactorias. Los resultados de los dominios demostraron correlación significativa con el resultado de calidad de vida general y de los ítems que evalúan la autopercepción de calidad de vida y de la salud, correlación significativa con el resultado global de depresión y diferencias estadísticamente significativas entre subgrupos de pacientes según variables socioeconómicas y clínicas. Conclusiones: El WHOQOL- HIV Bref se presentó como válido y confiable para medir la calidad de vida de personas con HIV/SIDA. (AU)

Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls.

BACKGROUND: Psoriasis and obesity are somewhat related to a low-grade systemic inflammatory response. OBJECTIVES: To determine leptin and adiponectin levels in psoriasis patients compared to control patients matched for weight. METHODS: A case-control study was performed, evaluating 113 psoriasis patients and 41 controls with other dermatologic diseases. RESULTS: The prevalence of obesity was 33% in cases and 21.9% in controls. All evaluated comorbidities were more prevalent among cases. When stratified by weight, the comorbidities were more frequent in overweight patients. We found no correlation between being overweight (p=0.25), leptin (p=0.18) or adiponectin (p=0.762) levels and psoriasis severity. When overweight cases and controls were compared, we found differences in the adiponectin values (p= 0.04). The overweight cases had lower adiponectin levels than the overweight controls. We found no differences in the leptin dosage between cases and controls. The overweight cases had higher leptin values than the normal weight cases (p<0.001). STUDY LIMITATIONS: Several patients used systemic anti-inflammatory medication. CONCLUSIONS: The prevalence of obesity among psoriasis cases (33%) was higher than in the general population (17.4%). We did not find any correlation between severity of psoriasis and inflammatory cytokines and the condition of being overweight. The overweight cases had lower values of adiponectin than the overweight controls. It seems, therefore, that there is a relationship between adiponectin and psoriasis, but this relationship depends on the presence of obesity.

Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls

Abstract BACKGROUND: Psoriasis and obesity are somewhat related to a low-grade systemic inflammatory response. OBJECTIVES: To determine leptin and adiponectin levels in psoriasis patients compared to control patients matched for weight. METHODS: A case-control study was performed, evaluating 113 psoriasis patients and 41 controls with other dermatologic diseases. RESULTS: The prevalence of obesity was 33% in cases and 21.9% in controls. All evaluated comorbidities were more prevalent among cases. When stratified by weight, the comorbidities were more frequent in overweight patients. We found no correlation between being overweight (p=0.25), leptin (p=0.18) or adiponectin (p=0.762) levels and psoriasis severity. When overweight cases and controls were compared, we found differences in the adiponectin values (p= 0.04). The overweight cases had lower adiponectin levels than the overweight controls. We found no differences in the leptin dosage between cases and controls. The overweight cases had higher leptin values than the normal weight cases (p<0.001). STUDY LIMITATIONS: Several patients used systemic anti-inflammatory medication. CONCLUSIONS: The prevalence of obesity among psoriasis cases (33%) was higher than in the general population (17.4%). We did not find any correlation between severity of psoriasis and inflammatory cytokines and the condition of being overweight. The overweight cases had lower values of adiponectin than the overweight controls. It seems, therefore, that there is a relationship between adiponectin and psoriasis, but this relationship depends on the presence of obesity.

Association between obesity-related biomarkers and cognitive and motor development in infants.

BACKGROUND: This study aimed to verify the association between obesity-related biomarkers and cognitive and motor development in infants between 6 and 24 months of age. METHODS: A cross-sectional study was conducted with 50 infants and plasma levels of leptin, adiponectin, resistin, soluble tumor necrosis factor receptors 1 and 2 (sTNFR1 and sTNFR2), chemokines, brain-derived neurotrophic factor (BDNF), serum cortisol and redox status were measured. The Bayley-III test was utilized to evaluate cognitive and motor development, and multiple linear stepwise regression models were performed to verify the association between selected biomarkers and cognitive and motor development. RESULTS: A significant association was found among plasma leptin and sTNFR1 levels with cognitive composite scores, and these two independents variables together explained 37% of the variability of cognitive composite scores (p=0.001). Only plasma sTNFR1 levels were associated and explained 24% of the variability of motor composite scores (p=0.003). CONCLUSIONS: Plasma levels of sTNFR1 were associated with the increase in cognitive and motor development scores in infants between 6 and 24 months of age through a mechanism not directly related to excess body weight. Moreover, increase in plasma levels of leptin reduced the cognitive development in this age range.

Associated Clinical and Laboratory Markers of Donor on Allograft Function After Heart Transplant.

INTRODUCTION: Primary graft dysfunction is a major cause of mortality after heart transplantation. OBJECTIVE: To evaluate correlations between donor-related clinical/biochemical markers and the occurrence of primary graft dysfunction/clinical outcomes of recipients within 30 days of transplant. METHODS: The prospective study involved 43 donor/recipient pairs. Data collected from donors included demographic and echocardiographic information, noradrenaline administration rates and concentrations of soluble tumor necrosis factor receptors (sTNFR1 and sTNFR2), interleukins (IL-6 and IL-10), monocyte chemoattractant protein-1, C-reactive protein and cardiac troponin I. Data collected from recipients included operating, cardiopulmonary bypass, intensive care unit and hospitalization times, inotrope administration and left/right ventricular function through echocardiography. RESULTS: Recipients who developed moderate/severe left ventricular dysfunction had received organs from significantly older donors (P =0.020). Recipients from donors who required moderate/high doses of noradrenaline (>0.23 µg/kg/min) around harvesting time exhibited lower post-transplant ventricular ejection fractions (P =0.002) and required longer CPB times (P =0.039). Significantly higher concentrations of sTNFR1 (P =0.014) and sTNFR2 (P =0.030) in donors were associated with reduced intensive care unit times (≤5 days) in recipients, while higher donor IL-6 (P =0.029) and IL-10 (P =0.037) levels were correlated with reduced hospitalization times (≤25 days) in recipients. Recipients who required moderate/high levels of noradrenaline for weaning off cardiopulmonary bypass were associated with lower donor concentrations of sTNFR2 (P =0.028) and IL-6 (P =0.001). CONCLUSION: High levels of sTNFR1, sTNFR2, IL-6 and IL-10 in donors were associated with enhanced evolution in recipients. Allografts from older donors, or from those treated with noradrenaline doses >0.23 µg/kg/min, were more frequently affected by primary graft dysfunction within 30 days of surgery.

Associated clinical and laboratory markers of donor on allograft function after heart transplant

Abstract Introduction: Primary graft dysfunction is a major cause of mortality after heart transplantation. Objective: To evaluate correlations between donor-related clinical/biochemical markers and the occurrence of primary graft dysfunction/clinical outcomes of recipients within 30 days of transplant. Methods: The prospective study involved 43 donor/recipient pairs. Data collected from donors included demographic and echocardiographic information, noradrenaline administration rates and concentrations of soluble tumor necrosis factor receptors (sTNFR1 and sTNFR2), interleukins (IL-6 and IL-10), monocyte chemoattractant protein-1, C-reactive protein and cardiac troponin I. Data collected from recipients included operating, cardiopulmonary bypass, intensive care unit and hospitalization times, inotrope administration and left/right ventricular function through echocardiography. Results: Recipients who developed moderate/severe left ventricular dysfunction had received organs from significantly older donors (P =0.020). Recipients from donors who required moderate/high doses of noradrenaline (>0.23 µg/kg/min) around harvesting time exhibited lower post-transplant ventricular ejection fractions (P =0.002) and required longer CPB times (P =0.039). Significantly higher concentrations of sTNFR1 (P =0.014) and sTNFR2 (P =0.030) in donors were associated with reduced intensive care unit times (≤5 days) in recipients, while higher donor IL-6 (P =0.029) and IL-10 (P =0.037) levels were correlated with reduced hospitalization times (≤25 days) in recipients. Recipients who required moderate/high levels of noradrenaline for weaning off cardiopulmonary bypass were associated with lower donor concentrations of sTNFR2 (P =0.028) and IL-6 (P =0.001). Conclusion: High levels of sTNFR1, sTNFR2, IL-6 and IL-10 in donors were associated with enhanced evolution in recipients. Allografts from older donors, or from those treated with noradrenaline doses >0.23 µg/kg/min, were more frequently affected by primary graft dysfunction within 30 days of surgery.

Biological markers of Alzheimer's disease.

The challenges for establishing an early diagnosis of Alzheimer's disease (AD) have created a need for biomarkers that reflect the core pathology of the disease. The cerebrospinal fluid (CSF) levels of total Tau (T-tau), phosphorylated Tau (P-Tau) and beta-amyloid peptide (Aß42) reflect, respectively, neurofibrillary tangle and amyloid pathologies and are considered as surrogate markers of AD pathophysiology. The combination of low Aß42 and high levels of T-tau and P-Tau can accurately identify patients with AD at early stages, even before the development of dementia. The combined analysis of the CSF biomarkers is also helpful for the differential diagnosis between AD and other degenerative dementias. The development of these CSF biomarkers has evolved to a novel diagnostic definition of the disease. The identification of a specific clinical phenotype combined with the in vivo evidence of pathophysiological markers offers the possibility to make a diagnosis of AD before the dementia stage with high specificity.

Biological markers of Alzheimers disease / Biomarcadores da doenca de Alzheimer

The challenges for establishing an early diagnosis of Alzheimer’s disease (AD) have created a need for biomarkers that reflect the core pathology of the disease. The cerebrospinal fluid (CSF) levels of total Tau (T-tau), phosphorylated Tau (P-Tau) and beta-amyloid peptide (Aβ42) reflect, respectively, neurofibrillary tangle and amyloid pathologies and are considered as surrogate markers of AD pathophysiology. The combination of low Aβ42 and high levels of T-tau and P-Tau can accurately identify patients with AD at early stages, even before the development of dementia. The combined analysis of the CSF biomarkers is also helpful for the differential diagnosis between AD and other degenerative dementias. The development of these CSF biomarkers has evolved to a novel diagnostic definition of the disease. The identification of a specific clinical phenotype combined with the in vivo evidence of pathophysiological markers offers the possibility to make a diagnosis of AD before the dementia stage with high specificity.

O desafio de se estabelecer o diagnóstico precoce de doença de Alzheimer (DA) levou ao desenvolvimento de biomarcadores que reflitam os aspectos patológicos centrais da doença. As dosagens no líquor da proteína Tau total (T-Tau), Tau fosforilada (P-Tau) e peptídeo beta-amiloide (Aβ42) no líquido cefalorraquidiano (LCR) refletem, respectivamente, as patologias Tau e amiloide, sendo consideradas como marcadores da fisiopatologia da DA. Os biomarcadores do LCR podem identificar acuradamente pacientes com DA em estágios precoces da doença, mesmo antes do desenvolvimento da demência. A análise combinada dos biomarcadores permite também fazer o diagnóstico diferencial entre DA e outras demências degenerativas. O desenvolvimento dos biomarcadores de DA conduziu a uma nova definição diagnóstica da doença. A identificação de um fenótipo clínico específico associado a uma evidência fisiopatológica in vivo provida por um biomarcador possibilita estabelecer, com alta especificidade, o diagnóstico de DA antes do estágio demencial.

Evaluation of laboratory tests for dengue diagnosis in clinical specimens from consecutive patients with suspected dengue in Belo Horizonte, Brazil.

BACKGROUND: Dengue is a widely spread arboviral disease in tropical and subtropical regions of the world. Dengue fever presents clinical characteristics similar to other febrile illness. Thus laboratory diagnosis is important for adequate management of the disease. OBJECTIVES: The present study was designed to evaluate the diagnostic performance of real-time PCR and serological methods for dengue in a real epidemic context. STUDY DESIGN: Clinical data and blood samples were collected from consecutive patients with suspected dengue who attended a primary health care unit in Belo Horizonte, Brazil. Serologic methods and real-time PCR were performed in serum samples to confirm dengue diagnosis. RESULTS: Among the 181 consecutive patients enrolled in this study with suspected dengue, 146 were considered positive by serological criteria (positive NS1 ELISA and/or anti-dengue IgM ELISA) and 138 were positive by real-time PCR. Clinical criteria were not sufficient for distinguishing between dengue and non-dengue febrile illness. The PCR reaction was pre-optimized using samples from patients with known viral infection. It had similar sensitivity compared to NS1 ELISA (88% and 89%, respectively). We also evaluated three commercial lateral flow immunochromatographic tests for NS1 detection (BIOEASY, BIORAD and PANBIO). All three tests showed high sensitivity (94%, 91% and 81%, respectively) for dengue diagnosis. CONCLUSION: According to our results it can be suggested that lateral flow tests for NS1 detection are the most feasible methods for early diagnosis of dengue.

Acute promyelocytic leukemia presenting as an extradural mass

Acute promyelocytic leukemia is potentially a highly curable type of leukemia that usually presents with pancytopenia, coagulopathies and bleeding. We describe a case of an unusual presentation of acute promyelocytic leukemia. A 53 year-old male was admitted complaining of pain and weakness in his legs. He presented at examination a spastic paraparesis with a sensitive level at the eighth thoracic medullar (T8) segment. Magnetic resonance imaging showed a posterolateral extradural mass from T6 through T8 segments with medullar compression. A complete blood count showed anemia, thrombocytopenia and the presence of promyelocytes and blasts. Marrow examination was compatible with the diagnosis of acute promyelocytic leukemia by cytogenetics and polymerase chain reaction for the PML-RARα gene. He was treated with all-trans-retinoic acid therapy plus daunorubicin and presented an all-trans-retinoic acid syndrome. Despite hematological remission, the patient presented neurologic deterioration and had to be treated with radiotherapy (total dose 3000 cGy) of the extradural lesion. The patient evolved with severe sepsis and died without any recovery from his neurologic deficit. Extramedullary infiltration is a very rare complication in acute promyelocytic leukemia. Most cases are related to relapse after initial treatment with all-trans-retinoic acid. The skin and the central nervous system are the most frequently involved sites. This is possibly the first case reported of this condition in which the patient had a symptomatic extradural mass.

Acute promyelocytic leukemia presenting as an extradural mass.

Acute promyelocytic leukemia is potentially a highly curable type of leukemia that usually presents with pancytopenia, coagulopathies and bleeding. We describe a case of an unusual presentation of acute promyelocytic leukemia. A 53 year-old male was admitted complaining of pain and weakness in his legs. He presented at examination a spastic paraparesis with a sensitive level at the eighth thoracic medullar (T8) segment. Magnetic resonance imaging showed a posterolateral extradural mass from T6 through T8 segments with medullar compression. A complete blood count showed anemia, thrombocytopenia and the presence of promyelocytes and blasts. Marrow examination was compatible with the diagnosis of acute promyelocytic leukemia by cytogenetics and polymerase chain reaction for the PML-RARα gene. He was treated with all-trans-retinoic acid therapy plus daunorubicin and presented an all-trans-retinoic acid syndrome. Despite hematological remission, the patient presented neurologic deterioration and had to be treated with radiotherapy (total dose 3000 cGy) of the extradural lesion. The patient evolved with severe sepsis and died without any recovery from his neurologic deficit. Extramedullary infiltration is a very rare complication in acute promyelocytic leukemia. Most cases are related to relapse after initial treatment with all-trans-retinoic acid. The skin and the central nervous system are the most frequently involved sites. This is possibly the first case reported of this condition in which the patient had a symptomatic extradural mass.

Imunologia da retinocoroidite toxoplásmica / Immunology of the toxoplasmic retinochoroiditis

A infecção pelo Toxoplasma gondii é uma importante causa de doença ocular, tanto em indivíduos imunocomprometidos como em imunocompetentes. A patogênese da destruição retinocoroidiana associada a essa infecção ainda não está totalmente esclarecida. Nesta revisão, discute-se o papel do sistema imune no controle da infecção pelo Toxoplasma, especialmente, no olho.

Toxoplasma gondii infection is an important cause of ocular disease in both immunocompromised and immunocompetent subjects. The pathogenesis of retinochoroidal lesion associated with this infection is not fully understood. In this review, the role of the immune system in the control of Toxoplasma infection, especially in the eye, is discussed.

Acoustic analysis of prosody in Sydenham's chorea / Análise acústica da prosódia em coréia de Sydenham

There are few studies of language and speech in patients with Sydenham's chorea (SC). We have done an acoustic analysis of fundamental frequency (F0), duration and intensity of declarative and interrogative sentences made by 20 SC patients, 20 patients with rheumatic fever (RF) without chorea, and compared them with 20 healthy age-matched controls (CO). Each group included 12 females. We found that there is no difference between the RF and CO groups in all studied parameters. Patients with SC, however, presented with a speech characterized by decreased F0 range (difference between minimum and maximum F0), shorter duration of sentences, and higher intensity of the first syllable of sentences. The findings were not influenced by the nature of the sentences (i.e. , declarative or interrogative), but for all variables they were significantly more severe in males than females. In conclusion, we have demonstrated that patients with acute SC have an impairment of modulation of F0 and longer duration of emission of sentences, resulting in a monotone and slow speech. This pattern is similar to what has been described in other basal ganglia illnesses, such as Parkinson's disease, Huntington's disease and Wilson's disease.

Há poucos estudos sobre linguagem e fala em pacientes com coréia de Sydenham (CS). Fizemos uma análise acústica da freqüência fundamental (F0), duração e intensidade de sentenças declarativas e interrogativas feitas por 20 pacientes com CS, 20 pacientes com febre reumática (FR) sem coréia, comparando-os com 20 controles saudáveis e pareados por idade (CO). Cada grupo incluiu 12 mulheres. Foi encontrado que não há diferença entre os grupos FR e CO quanto a todos parâmetros estudados. Pacientes com CS, contudo, apresentaram-se com fala caracterizada pela redução da variação de F0 (diferença entre F0 mínima e máxima), duração mais curta das sentenças e maior intensidade da primeira sílaba das sentenças. Os achados não foram influenciados pela natureza das sentenças (i.e. , declarativas ou interrogativas), mas os achados foram mais evidentes em todas as variáveis em homens em contraste com mulheres. Em conclusão, demonstramos que pacientes com CS aguda têm prejuízo da modulação da F0 e duração mais longa da emissão de sentenças, resultando em fala mais lenta e monótona. Esse padrão é semelhante ao que tem sido descrito em outras fecções dos núcleos da base, tais como doença de Parkinson, doença de Huntington e doença de Wilson.

[Immunology of the toxoplasmic retinochoroiditis]. / Imunologia da retinocoroidite toxoplásmica.

Toxoplasma gondii infection is an important cause of ocular disease in both immunocompromised and immunocompetent subjects. The pathogenesis of retinochoroidal lesion associated with this infection is not fully understood. In this review, the role of the immune system in the control of Toxoplasma infection, especially in the eye, is discussed.

Citocinas e quimiocinas no transplante renal / Cytokines and chemokines in renal transplantation

O transplante renal é a melhor modalidade de terapia renal substitutiva até o momento. Infelizmente a sobrevida do enxerto é interrompida pelos episódios de rejeição aguda ou mesmo de fibrose intersticial atrofia tubular. A dosagem de quimiocinas e citrocinas urinárias como ferramenta alternativa para o diagnóstico dessas complicações tem sido relatada nos últimos anos. Estas substâncias estão sabidamente relacionadas com os mecanismos imunoinflamatórios do transplante renal podendo ser detectadas no tecido renal no plasma e na urina de pacientes transplantados. Drogas anti-inflamatórias inibidores do sistema renina angiotensina e alguns antagonistas de receptores de citocinas ainda utilizados em nível experimental podem interferir com a expressão desses mediadores do sistema imune e por conseguinte alterar a evolução do transplante renal. Neste sentido pretende-se neste artigo fazer uma revisão dos estudos sobre a mensuração de citocinas quimiocinas e dos seus receptores na urina no plasma e no tecido renal de pacientes transplantados no intuito de avaliar uma possível associação entre os níveis desses mediadores e as complicações do transplante renal e sobrevida do enxerto.

Renal transplantation is the best modality of renal replacement therapy so far. Unfortunately, graft survival is interrupted by episodes of acute rejection or tubular atrophy of interstitial fibrosis. The measurement of urinary chemokines and citrocinas as an alternative tool for the diagnosis of these complications have been reported in recent years. These substances are known to be related to immunoinflammatory mechanisms of renal transplantation can be detected in renal tissue in plasma and urine of transplant patients. Anti-inflammatory drugs inhibiting the renin angiotensin receptor antagonists and some cytokines also used on an experimental level can interfere with the expression of these mediators of the immune system and thus alter the course of renal transplantation. In this sense we intend to make this article a review of studies on the measurement of cytokines chemokines and their receptors in the plasma and urine in the renal tissue of patients transplanted in order to evaluate a possible association between the levels of these mediators and the complications of the transplant and renal graft survival.

Participação dos núcleos da base no controle do tônus e da locomoção / Basal ganglia participation in tone and locomotion control

INTRODUÇÃO: Nas duas últimas décadas, muitos estudos investigaram os circuitos constituídos pelos núcleos da base. É bem conhecido o papel desses agrupamentos neuronais no controle dos movimentos voluntários, especificamente através de suas conexões com o córtex motor, o que constitui o circuito fronto-estriatal motor. Entretanto, poucos estudos discutem a função dos núcleos da base na regulação do tônus e da locomoção. OBJETIVOS: realizar um levantamento, por meio de dados expostos na literatura, sobre o papel dos núcleos da base no controle do tônus e da locomoção, aplicando-se no modelo da doença de Parkinson. METODOLOGIA: Foi realizada uma busca utilizando os bancos de dados Pubmed, Scielo e Lilacs, no período de janeiro de 1998 a julho de 2008. RESULTADOS: Os núcleos da base, principalmente a substância negra reticulada, contribuem para o controle do sistema inibitório do tônus muscular postural e do sistema de execução da locomoção, mediante as suas projeções para núcleos localizados no tronco encefálico. Na doença de Parkinson, com a depleção dopaminégica ocorrem alterações na modulação desses núcleos localizados no tronco encefálico pelos núcleos da base, o que contribui para o surgimento da rigidez e das alterações da marcha. CONCLUSÃO: Os núcleos da base exercem papel importante no controle do tônus muscular postural e no controle da locomoção, através de projeções para o tronco encefálico.

INTRODUCTION: In the past two decades, many studies have been investigating the circuits composed by the basal ganglia. The role of these neural groups in the control of the voluntary movements is well known, particularly through its connections with the motor cortex, which constitutes the frontostriatal motor circuit. However, few studies discuss the function of thebasal ganglia in the regulation of the tone and of the locomotion. OBJECTIVE: to carry out an investigation on the role of the basal ganglia in the control of the tone and of the locomotion by means of the data available in the literature, applying it in the model of Parkinson’s disease. METHODOLOGY: the search was executed by using “PubMed”, “Scielo” and “Lilacs” databases, from January 1998 to July 2008. RESULTS: The basal ganglia, especially thesubstsantia nigra pars reticulata, contribute to the control of the inhibitory system of the posturalmuscle tone and of the locomotion system, by means of its projections for localized ganglia in the brainstem. In Parkinson’s disease, the dopaminergic depletion brings about alterations in themodulation of these ganglia, situated in the brainstem by the basal ganglia, which contributes to the appearance of rigidity and gait alterations. CONCLUSION: The basal ganglia perform an important role in the control of the postural muscle tone and in the control of locomotion, by means of projections to the brainstem.

Correlation between migraine subtipes and depression / Correlação entre subtipos de migrânea e depressão

This study has evaluated depression in patients with episodic migraine (n=98), chronic migraine without medication overuse (n=23), and chronic migraine with medication overuse (n=57). The Beck Depression Inventory (BDI) was used to evaluate depressive symptoms in these three groups. The mean BDI score obtained in all patients was higher than that observed in asymptomatic subjects (episodic migraine=16.09±11.79, chronic migraine with medication overuse=18.91±12.53, chronic migraine without medication overuse=19.83±14.79). This finding corroborates previous studies suggesting a co-morbid association between migraine and depression. Depression did not seem to be crucial in the transformation of migraine as the median BDI scores did not differ significantly between patients with episodic and chronic migraine. The median BDI scores of the patients with chronic migraine with medication overuse and that patients with chronic migraine without medication overuse were similar as well. Therefore, medication overuse behavior may not be related with depression.

Este estudo avaliou a depressão em pacientes com migrânea episódica (n=98), migrânea crônica com uso abusivo de analgésicos (n=57) e migrânea crônica sem uso abusivo de medicamentos analgésicos (n=23). O Inventário de Depressão de Beck (IDB) foi usado para avaliar sintomas depressivos nos três grupos. As médias dos escores de IDB encontradas (migrânea episódica=16.09±11.79, migrânea crônica com uso abusivo de analgésicos=18.91±12.53, migrânea crônica sem uso abusivo de analgésicos=19.83±14.79) foram maiores do que as observadas em indivíduos assintomáticos. Tais resultados confirmam estudos prévios indicando uma relação de comorbidade entre migrânea e depressão. Os dados não sugerem que a depressão seja um fator determinante da transformação da migrânea episódica em migrânea crônica, pois nestes dois grupos as medianas dos escores de IDB foram semelhantes. Os escores de IDB foram semelhantes entre os pacientes com migrânea crônica com e sem uso abusivo de analgésicos. Portanto, o comportamento de ingerir abusivamente analgésicos não parece estar relacionado com a depressão.

Papel das quimiocinas na resposta inflamatória da pré-eclampsia / The Function of the inflammatory response of preeclampsia

A pré-eclampsia é uma doença de acometimento sistêmico. Apesar de sua etiologia ser incerta, está bem estabelecido que os defeitos da invasão trofoblástica durante a implantação no útero contribuem para a redução da perfusão placentária. Este fato sugere que, devido a uma isquemia placentária e à produção de fatores citotóxicos, desencadeia-se uma agressão ao endotélio. Os fatores são desconhecidos, mas sabe-se que as citocinas são potentes ativadores do endotélio vascular e podem agir como mediadores da disfunção endotelial na pré-eclampsia. A ação de quimiocinas, peptídeos da família das citocinas, é de atração de leucócitos para determinados tecidos, por exemplo, a placenta, encontrando-se em níveis elevados na pré-eclampsia. Tudo leva a crer que a resposta inflamatória do organismo está exacerbada e relacionada à gravidade da pré-eclampsia.